STRATA CRITICAL MEDICAL, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -16.70% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-03
- STRATA CRITICAL MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2021-12-31 was 2.35%.
- STRATA CRITICAL MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2020-12-31 was 0.00%.
- STRATA CRITICAL MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -16.70%.
- STRATA CRITICAL MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was 0.00%.
- STRATA CRITICAL MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was 0.00%.
- STRATA CRITICAL MEDICAL, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2021 was 0.02%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | -16.70% 10-K · filed 2026-03-03 | -6.76% 10-K · filed 2025-03-13 | |
| 2023-12-31 | 0.00% 10-K · filed 2025-03-13 | -2.74% 10-K · filed 2024-03-12 | |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-12 | ||
| 2021-12-31 | 2.35% 8-K · filed 2023-01-10 | ||
| 2021-09-30 | 0.02% 10-K · filed 2021-12-20 | ||
| 2020-12-31 | 0.00% 8-K · filed 2023-01-10 | ||
| 2020-09-30 | -0.30% 10-K · filed 2021-12-20 | ||
| 2019-09-30 | -0.30% 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |